Comparison of the efficacy and safety of leflunomide versus placebo combined with basic prednisone therapy in patients with active disease phase of Takayasu arteritis: study protocol for a randomized, double-blinded controlled trial (Takayasu arteritis clinical trial in China: TACTIC).
Therapeutic advances in chronic disease（2023）
摘要
ClinicalTrials.gov identifier: NCT02981979.
更多查看译文
关键词
Takayasu arteritis,double-blinded controlled trial,leflunomide,placebo,randomized
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要